Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial.
Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence MS, Redwood S, Kahlert P, Rodes-Cabau J, Leipsic J, Webb J.
Vahanian A, et al. Among authors: wendler o.
EuroIntervention. 2016 Jun 12;12(2):e235-43. doi: 10.4244/EIJV12I2A37.
EuroIntervention. 2016.
PMID: 27290682
Free article.
Clinical Trial.